keyword
https://read.qxmd.com/read/38622390/immune-homeostasis-maintenance-through-advanced-immune-therapeutics-to-target-atherosclerosis
#21
JOURNAL ARTICLE
Shuo Geng, Yajun Wu, Liwu Li
Atherosclerosis remains the leading cause of coronary heart disease (CHD) with enormous health and societal tolls. Traditional drug development approaches have been focused on small molecule-based compounds that aim to lower plasma lipids and reduce systemic inflammation, two primary causes of atherosclerosis. However, despite the widely available lipid-lowering and anti-inflammatory small compounds and biologic agents, CHD prevalence still remains high. Based on recent advances revealing disrupted immune homeostasis during atherosclerosis pathogenesis, novel strategies aimed at rejuvenating immune homeostasis with engineered immune leukocytes are being developed...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38622288/transcriptional-regulation-and-post-translational-modifications-in-the-glycolytic-pathway-for-targeted-cancer-therapy
#22
REVIEW
Xuan Ni, Cheng-Piao Lu, Guo-Qiang Xu, Jing-Jing Ma
Cancer cells largely rely on aerobic glycolysis or the Warburg effect to generate essential biomolecules and energy for their rapid growth. The key modulators in glycolysis including glucose transporters and enzymes, e.g. hexokinase 2, enolase 1, pyruvate kinase M2, lactate dehydrogenase A, play indispensable roles in glucose uptake, glucose consumption, ATP generation, lactate production, etc. Transcriptional regulation and post-translational modifications (PTMs) of these critical modulators are important for signal transduction and metabolic reprogramming in the glycolytic pathway, which can provide energy advantages to cancer cell growth...
April 15, 2024: Acta Pharmacologica Sinica
https://read.qxmd.com/read/38622277/factor-xi-structure-function-and-therapeutic-inhibition
#23
REVIEW
Ahmed E Ali, Richard C Becker
Arterial and venous thromboembolism is a major medical concern that requires therapeutic anticoagulation in various medical fields to prevent its drastic consequences. Despite significant advances in anticoagulant therapy, thrombosis remains a leading cause of morbidity and mortality worldwide. Traditional anticoagulants like heparin and vitamin K antagonists (VKAs) have shown efficacy in preventing and treating thrombosis but come with an inherent risk of bleeding due to their non-specific inhibition of multiple coagulation factors...
April 16, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38622060/identifying-potential-sos1-inhibitors-via-virtual-screening-of-multiple-small-molecule-libraries-against-kras-sos1-interface
#24
JOURNAL ARTICLE
Saima Ikram, Ehsan Sayyah, Serdar Durdagi
The RAS-MAPK signaling pathway, crucial for cell proliferation and differentiation, involves key proteins KRAS and SOS1. Mutations in the KRAS and SOS1 genes are implicated in various cancer types, including pancreatic, lung, and juvenile myelomonocytic leukemia. There is considerable interest in identifying inhibitors targeting KRAS and SOS1 to explore potential therapeutic strategies for cancer treatment. In this study, advanced in silico techniques were employed to screen small molecule libraries at this interface, leading to the identification of promising lead compounds as potential SOS1 inhibitors...
April 15, 2024: Chembiochem: a European Journal of Chemical Biology
https://read.qxmd.com/read/38622050/lipid-nanoparticle-mediated-small-interfering-rna-delivery-as-a-potential-therapy-for-alzheimer-s-disease
#25
REVIEW
Tanvir Ahmed
Alzheimer's disease (AD) is a neurodegenerative condition that exhibits a gradual decline in cognitive function and is prevalent among a significant number of individuals globally. The use of small interfering RNA (siRNA) molecules in RNA interference (RNAi) presents a promising therapeutic strategy for AD. Lipid nanoparticles (LNPs) have been developed as a delivery vehicle for siRNA, which can selectively suppress target genes, by enhancing cellular uptake and safeguarding siRNA from degradation. Numerous research studies have exhibited the effectiveness of LNP-mediated siRNA delivery in reducing amyloid beta (Aβ) levels and enhancing cognitive function in animal models of AD...
April 15, 2024: European Journal of Neuroscience
https://read.qxmd.com/read/38621994/-identification-of-1-3-8-triazaspiro-4-5-decane-2-4-dione-derivatives-as-a-novel-delta-opioid-receptor-selective-agonist-chemotype
#26
JOURNAL ARTICLE
Yazan J Meqbil, Jhoan Aguilar, Arryn T Blaine, Lan Chen, Robert J Cassell, Amynah A Pradhan, Richard M van Rijn
Delta opioid receptors hold potential as a target for neurological and psychiatric disorders, yet no delta opioid receptor agonist has proven efficacious in critical phase II clinical trials. The exact reasons for the failure to produce quality drug candidates for the delta opioid receptor is nuclear. However, it is known that certain delta opioid receptor agonists can induce seizures and exhibit tachyphylaxis. Several studies have suggested that those adverse effects are more prevalent in delta agonists that share the SNC80/BW373U86 chemotype...
April 15, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/38621756/synthetic-biology-approaches-to-posttranslational-regulation-in-plants
#27
REVIEW
Inna A Abdeeva, Yulia S Panina, Liliya G Maloshenok
To date synthetic biology approaches involving creation of functional genetic modules are used in a wide range of organisms. In plants, such approaches are used both for research in the field of functional genomics and to increase the yield of agricultural crops. Of particular interest are methods that allow controlling genetic apparatus of the plants at post-translational level, which allow reducing non-targeted effects from interference with the plant genome. This review discusses recent advances in the plant synthetic biology for regulation of the plant metabolism at posttranslational level and highlights their future directions...
January 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38621622/circhipk3-targets-drp1-to-mediate-hydrogen-peroxide-induced-necroptosis-of-vascular-smooth-muscle-cells-and-atherosclerotic-vulnerable-plaque-formation
#28
JOURNAL ARTICLE
Xiaolu Li, Yanyan Yang, Zhibin Wang, Xiaotong Lin, Xiuxiu Fu, Xiangqin He, Meixin Liu, Jian-Xun Wang, Tao Yu, Pin Sun
INTRODUCTION: Necroptosis triggered by H2 O2 is hypothesized to be a critical factor in the rupture of atherosclerotic plaques, which may precipitate acute cardiovascular events. Nevertheless, the specific regulatory molecules of this development remain unclear. We aims to elucidate a mechanism from the perspective of circular RNA. OBJECTIVES: There are few studies on circRNA in VSMCs necroptosis. The objective of our research is to shed light on the intricate roles that circHIPK3 plays in the process of necroptosis in VSMCs and the development of atherosclerotic plaques that are prone to rupture...
April 13, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38621327/modulators-for-palmitoylation-of-proteins-and-small-molecules
#29
REVIEW
Zeshuai Fan, Yuchen Hao, Yidan Huo, Fei Cao, Longfei Li, Jianmei Xu, Yali Song, Kan Yang
As an essential form of lipid modification for maintaining vital cellular functions, palmitoylation plays an important role in in the regulation of various physiological processes, serving as a promising therapeutic target for diseases like cancer and neurological disorders. Ongoing research has revealed that palmitoylation can be categorized into three distinct types: N-palmitoylation, O-palmitoylation and S-palmitoylation. Herein this paper provides an overview of the regulatory enzymes involved in palmitoylation, including palmitoyltransferases and depalmitoylases, and discusses the currently available broad-spectrum and selective inhibitors for these enzymes...
April 12, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38621319/expanding-the-ligand-spaces-for-e3-ligases-for-the-design-of-protein-degraders
#30
REVIEW
Rahman Shah Zaib Saleem, Martin P Schwalm, Stefan Knapp
Targeted protein degradation (TPD) has recently emerged as an exciting new drug modality. However, the strategy of developing small molecule-based protein degraders has evolved over the past two decades and has now established molecular tags that are already in clinical use, as well as chimeric molecules, PROteolysis TArgeting Chimeras (PROTACs), based mainly on ligand systems developed for the two E3 ligases CRBN and VHL. The large size of the human E3 ligase family suggests that PROTACs can be developed by targeting a large diversity of E3 ligases, some of which have restricted expression patterns with the potential to design disease- or tissue-specific degraders...
April 12, 2024: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/38619695/the-role-of-micrornas-in-the-diagnosis-and-treatment-of-oral-premalignant-disorders
#31
REVIEW
J H Shazia Fathima, Selvaraj Jayaraman, Ramya Sekar, Nazmul Huda Syed
Oral premalignant disorders (OPMDs) are a group of potentially malignant conditions that pose a significant health burden globally. MicroRNAs (miRNAs), small non-coding RNA molecules, have emerged as crucial regulators of gene expression and have been implicated in various biological processes, including carcinogenesis. This review synthesizes existing knowledge to provide a comprehensive understanding of the molecular mechanisms underlying OPMDs and to highlight the potential of miRNAs as promising biomarkers and therapeutic targets...
April 15, 2024: Odontology
https://read.qxmd.com/read/38619514/-exploring-the-mechanisms-of-jujing-pill-on-varicocele-associated-male-infertility-via-network-pharmacology-and-molecular-docking-technology
#32
JOURNAL ARTICLE
Kai-Sen Liao, Heng Wang, Yong-Sheng Jiang, Jian-Huai Chen, Xing Zhang, Zhi-Xing Sun, Yun Chen
OBJECTIVE: To investigate the potential mechanism of treating varicocele-associated male infertility with Jujing pill using network pharmacology and molecular docking technology. METHODS: The TCMSP and BATMAN databases were used to search for the Chinese medicine components of the Jujing pill and obtain the corresponding targets. The databases GeneCards, DISGENET, OMIM, and HPO were searched for 'varicocele' and 'male infertility' to identify the potential targets of varicocele-associated male infertility...
August 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38619318/discovery-of-a-pocket-network-on-the-domain-5-of-the-trkb-receptor-a-potential-new-target-in-the-quest-for-the-new-ligands
#33
JOURNAL ARTICLE
Mirjana Antonijevic, Jana Sopkova-de Oliveira Santos, Patrick Dallemagne, Christophe Rochais
The important role that the neurotrophin tyrosine kinase receptor - TrkB has in the pathogenesis of several neurodegenerative conditions such are Alzheimer's disease, Parkinson's disease, Huntington's disease, has been well described. This shouldn't be a surprise, since in the physiological conditions, once activated by brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5), the TrkB receptor promotes neuronal survival, differentiation and synaptic function. Considering that the natural ligands for TrkB receptor are large proteins, it is a challenge to discover small molecule capable to mimic their effects...
April 15, 2024: Molecular Informatics
https://read.qxmd.com/read/38618996/investigation-of-the-mechanism-of-nephrotoxicity-of-nux-vomica-by-ptgs2-cyp2c9-mediated-arachidonic-acid-pathway-and-jian-pi-tong-luo-compound-s-protective-effect
#34
JOURNAL ARTICLE
Na Zhang, Baisong An, Liangyou Zhao, Dapeng Zhao, Bochuan Lv, Shumin Liu
The clinical effectiveness of nux-vomica in treating rheumatism and arthralgia is noteworthy; however, its nephrotoxicity has sparked global concerns. Hence, there is value in conducting studies on detoxification methods based on traditional Chinese medicine compatibility theory. Blood biochemistry, enzyme-linked immunosorbent assay, and pathological sections were used to evaluate both the nephrotoxicity of nux-vomica and the efficacy of the Jian Pi Tong Luo (JPTL) compound in mitigating this toxicity. Kidney metabolomics, using ultra-high-performance liquid chromatography-quadrupole-time-of-flight-MS (UPLC-Q-TOF-MS), was applied to elucidate the alterations in small-molecule metabolites in vivo...
April 15, 2024: Biomedical Chromatography: BMC
https://read.qxmd.com/read/38618911/zinc-chelating-bet-bromodomain-inhibitors-equally-target-islet-endocrine-cell-types
#35
JOURNAL ARTICLE
Rachel A Jones Lipinski, Jennifer S Stancill, Raymundo Nuñez, Sarah L Wynia-Smith, Daniel J Sprague, Joshua A Nord, Amir Bird, John A Corbett, Brian C Smith
Inhibition of the bromodomain and extraterminal domain (BET) protein family is a potential strategy to prevent and treat diabetes; however, the clinical use of BET bromodomain inhibitors (BETi) is associated with adverse effects. Here, we explore a strategy for targeting BETi to β-cells by exploiting the high zinc (Zn2+ ) concentration in β-cells relative to other cell types. We report the synthesis of a novel, Zn2+ -chelating derivative of the pan-BETi (+)-JQ1, (+)-JQ1-DPA, in which (+)-JQ1 was conjugated to dipicolyl amine (DPA)...
April 15, 2024: American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
https://read.qxmd.com/read/38618612/natural-product-inspired-molecules-for-covalent-inhibition-of-shp2-tyrosine-phosphatase
#36
JOURNAL ARTICLE
Weida Liang, Aaron D Krabill, Katelyn S Gallagher, Christine Muli, Zihan Qu, Darci Trader, Zhong-Yin Zhang, Mingji Dai
Natural products have been playing indispensable roles in the development of lifesaving drug molecules. They are also valuable sources for covalent protein modifiers. However, they often are scarce in nature and have complex chemical structures, which are limiting their further biomedical development. Thus, natural product-inspired small molecules which still contain the essence of the parent natural products but are readily available and amenable for structural modification, are important and desirable in searching for lead compounds for various disease treatment...
April 28, 2024: Tetrahedron
https://read.qxmd.com/read/38618492/extracellular-vesicles-and-their-therapeutic-applications-a-review-article-part1
#37
REVIEW
Diana Rafieezadeh, Aryan Rafieezadeh
Extracellular vesicles (EVs) have emerged as a captivating field of study in molecular biology with diverse applications in therapeutics. These small membrane-bound structures, released by cells into the extracellular space, play a vital role in intercellular communication and hold immense potential for advancing medical treatments. EVs, including exosomes, microvesicles, and apoptotic bodies, are classified based on size and biogenesis pathways, with exosomes being the most extensively studied. The aim of this study was to examine the molecular secretory pathway of exosomes and to discuss the medical applications of exosomes and the methods for employing them in laboratory models...
2024: International Journal of Physiology, Pathophysiology and Pharmacology
https://read.qxmd.com/read/38618249/small-molecule-deoxynyboquinone-triggers-alkylation-and-ubiquitination-of-keap1-at-cys489-on-kelch-domain-for-nrf2-activation-and-inflammatory-therapy
#38
JOURNAL ARTICLE
Ke-Gang Linghu, Tian Zhang, Guang-Tao Zhang, Peng Lv, Wen-Jun Zhang, Guan-Ding Zhao, Shi-Hang Xiong, Qiu-Shuo Ma, Ming-Ming Zhao, Meiwan Chen, Yuan-Jia Hu, Chang-Sheng Zhang, Hua Yu
Activation of nuclear factor erythroid 2-related factor 2 (Nrf2) by Kelch-like ECH-associated protein 1 (Keap1) alkylation plays a central role in anti-inflammatory therapy. However, activators of Nrf2 through alkylation of Keap1-Kelch domain have not been identified. Deoxynyboquinone (DNQ) is a natural small molecule discovered from marine actinomycetes. The current study was designed to investigate the anti-inflammatory effects and molecular mechanisms of DNQ via alkylation of Keap1. DNQ exhibited significant anti-inflammatory properties both in vitro and in vivo ...
March 2024: Journal of Pharmaceutical Analysis
https://read.qxmd.com/read/38618202/efficacy-and-safety-of-gst-hg171-in-adult-patients-with-mild-to-moderate-covid-19-a-randomised-double-blind-placebo-controlled-phase-2-3-trial
#39
JOURNAL ARTICLE
Hongzhou Lu, George Zhang, John Mao, Xiaochun Chen, Yangqing Zhan, Ling Lin, Tianxiang Zhang, Yanan Tang, Feng Lin, Feiyue Zhu, Yuanlong Lin, Yiming Zeng, Kaiyu Zhang, Wenfang Yuan, Zhenyu Liang, Ruilin Sun, Liya Huo, Peng Hu, Yihua Lin, Xibin Zhuang, Zhaohui Wei, Xia Chen, Wenhao Yan, Xiuping Yan, Lisa Mu, Zhuhua Lin, Xinyu Tu, Hongshan Tan, Fuhu Huang, Zhiqiang Hu, Hongming Li, Guoping Li, Haijun Fu, Zifeng Yang, Xinwen Chen, Fu-Sheng Wang, Nanshan Zhong
BACKGROUND: GST-HG171 is a potent, broad-spectrum, orally bioavailable small-molecule 3C like protease inhibitor that has demonstrated greater potency and efficacy compared to Nirmatrelvir in pre-clinical studies. We aimed to evaluate the efficacy and safety of orally administered GST-HG171 plus Ritonavir in patients with coronavirus disease 2019 (COVID-19) infected with emerging XBB and non-XBB variants. METHODS: This randomised, double-blind, placebo-controlled phase 2/3 trial was conducted in 47 sites in China among adult patients with mild-to-moderate COVID-19 with symptoms onset ≤72 h...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38617842/therapy-for-hormone-receptor-positive-human-epidermal-growth-receptor-2-negative-metastatic-breast-cancer-following-treatment-progression-via-cdk4-6-inhibitors-a-literature-review
#40
REVIEW
Meixi Ye, Hao Xu, Jinhua Ding, Li Jiang
Endocrine therapy (ET) with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) is currently the first-line standard treatment for most patients with hormone receptor-positive (HR+) and human epidermal growth receptor 2-negative (HER2-) metastatic or advanced breast cancer. However, the majority of tumors response to and eventually develop resistance to CDK4/6is. The mechanisms of resistance are poorly understood, and the optimal postprogression treatment regimens and their sequences continue to evolve in the rapidly changing treatment landscape...
2024: Breast Cancer: Targets and Therapy
keyword
keyword
73045
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.